JANUX THERAPEUTICS INC's ticker is JANX and the CUSIP is 47103J105. A total of 45 filers reported holding JANUX THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $283 | -99.9% | 21,469 | -35.6% | 0.04% | -37.7% |
| Q3 2022 | $452,000 | +9.7% | 33,352 | -1.2% | 0.07% | -5.5% |
| Q2 2022 | $412,000 | +1.7% | 33,750 | +19.4% | 0.07% | +10.6% |
| Q1 2022 | $405,000 | -36.1% | 28,258 | -12.0% | 0.07% | -38.9% |
| Q4 2021 | $634,000 | +41.2% | 32,128 | +54.6% | 0.11% | +100.0% |
| Q3 2021 | $449,000 | – | 20,777 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 8,670,644 | $117,401,000 | 2.50% |
| 5AM Venture Management, LLC | 446,266 | $6,042,000 | 1.16% |
| Samsara BioCapital, LLC | 360,414 | $4,880,000 | 1.14% |
| BVF INC/IL | 1,470,334 | $19,908,000 | 0.82% |
| Orbimed Advisors | 2,836,386 | $38,405,000 | 0.71% |
| EcoR1 Capital, LLC | 1,421,319 | $19,245,000 | 0.57% |
| Woodline Partners LP | 400,181 | $5,418,000 | 0.08% |
| Parkwood LLC | 33,352 | $452,000 | 0.07% |
| JANUS HENDERSON GROUP PLC | 3,920,088 | $26,572,546 | 0.02% |
| Cerity Partners LLC | 105,933 | $1,434,000 | 0.02% |